Review





Similar Products

95
MedChemExpress medchemexpress hy 10971 tcs7010 medchemexpress hy
Medchemexpress Hy 10971 Tcs7010 Medchemexpress Hy, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/medchemexpress hy 10971 tcs7010 medchemexpress hy/product/MedChemExpress
Average 95 stars, based on 1 article reviews
medchemexpress hy 10971 tcs7010 medchemexpress hy - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

93
Selleck Chemicals tcs7010 s1451
A HeLa cells were transfected with AURKA siRNA-1, AURKA siRNA-2, or control siRNA. These cells were treated with BMH-21 or DMSO, and were synchronized at M phase by nocodazole and harvested by shaking off. Immunoprecipitation was performed with anti-pan-phospho-serine/threonine antibody. The immunoprecipitates were immunoblotted with the indicated antibodies. B HeLa cells were transfected with the indicated doses of Flag-AURKA plasmid or Flag-vector. These cells were treated with BMH-21 or DMSO, and were synchronized at M phase and harvested as described in ( A ). Immunoprecipitation was performed with anti-pan-phospho-serine/threonine antibody. The immunoprecipitates were immunoblotted with the indicated antibodies. C HeLa cells were treated with 0 μM, 5 μM, 10 μM, and 15 μM <t>TCS7010.</t> These cells were treated with BMH-21 or DMSO, and were synchronized at M phase and harvested as described in ( A ). Immunoprecipitation was performed with anti-pan-phospho-serine/threonine antibody. The immunoprecipitates were immunoblotted with the indicated antibodies. D In vitro phosphorylation experiment was performed using purified His-AURKA and GST-SMC2. Proteins were resolved by SDS-PAGE and probed with anti-pan-phospho-lysine antibody. Coomassie blue staining showed the purified proteins. E Sequence alignment of the AURKA phosphorylation consensus within SMC2 and substrates of AURKA. Phosphorylated threonine residues are highlighted in red, arginine at the n − 3 position is highlighted in green, and hydrophobic residues at the n + 1 position are highlighted in blue. F In vitro phosphorylation experiment was performed using purified His-AURKA and GST-SMC2 T574A. Proteins were resolved by SDS-PAGE and probed with the indicated antibodies. Coomassie blue staining showed the purified proteins. G HeLa cells were transfected with the indicated siRNAs and the indicated plasmids (left). A quantitative comparison of multinucleated cells in HeLa cells in the indicated circumstances is shown ( n > 500) (right). ** p < 0.01. *** p < 0.001. **** p < 0.0001. n.s. denotes no significance.
Tcs7010 S1451, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tcs7010 s1451/product/Selleck Chemicals
Average 93 stars, based on 1 article reviews
tcs7010 s1451 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

94
MedChemExpress aurora a inhibitor tcs7010
a Representative RPE-1 cells expressing CENP-A-GFP and centrin1-GFP (gray, centrioles circled) after indicated treatments, showing enlarged insets of polar (P) and aligned (A) kinetochores immunostained for pT232-Aurora B (red). b Ratio of pT232-Aurora B intensity normalized to CENP-A on polar vs. aligned kinetochores per cell under indicated treatments. Colored points represent individual cells; black lines show the mean, with light and dark gray areas marking 95% confidence intervals for the mean and standard deviation, respectively. c Average pT232-Aurora B levels normalized to CENP-A on all kinetochore groups after indicated treatments. Dispersion measures as in ( b ). d Representative cells expressing CENP-A-GFP and centrin1-GFP (cyan, centrioles circled) immunostained for pT232-Aurora B (red) and α-tubulin (gray) after continuous CENP-E inhibition and acute Aurora A inhibition by MLN8054 and <t>TCS7010,</t> with enlarged insets of polar (P) and aligned (A) kinetochores. e – g Quantification of pT232-Aurora B intensity ratio on polar vs. aligned kinetochores e , number of polar chromosomes f , and spindle length g after indicated treatments. Dispersion measures as in ( b) . h RPE-1 cells expressing CENP-A-GFP and centrin-GFP (red, centrioles circled), immunostained for α-tubulin (gray), and imaged by super-resolution Airyscan microscopy showing enlarged insets of congressing (C) and aligned (A) kinetochores. Images are deconvolved projections of 2–5 z-planes. Numbers: b 23, 18, 14, 27 cells averaged from 491 kinetochore pairs, c 83, 71, 61, 57, 47, 41, 52, 79 kinetochore pairs from 91 cells, e 22, 19, 17, 18 cells averaged from 436 kinetochore pairs, f , g 39, 38, 42, 38 cells, all pooled from ≥2 independent biological replicates. Statistics: two-tailed ANOVA with post-hoc Tukey’s HSD test. Symbols indicate: n.s., p > 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; ****, p ≤ 0.0001; inh., inhibited; chrom., chromosomes; MLN, MLN8237. Source data are provided as a Source Data file.
Aurora A Inhibitor Tcs7010, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aurora a inhibitor tcs7010/product/MedChemExpress
Average 94 stars, based on 1 article reviews
aurora a inhibitor tcs7010 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
MedChemExpress aurora b inhibitory activity
a Representative RPE-1 cells expressing CENP-A-GFP and centrin1-GFP (gray, centrioles circled) after indicated treatments, showing enlarged insets of polar (P) and aligned (A) kinetochores immunostained for pT232-Aurora B (red). b Ratio of pT232-Aurora B intensity normalized to CENP-A on polar vs. aligned kinetochores per cell under indicated treatments. Colored points represent individual cells; black lines show the mean, with light and dark gray areas marking 95% confidence intervals for the mean and standard deviation, respectively. c Average pT232-Aurora B levels normalized to CENP-A on all kinetochore groups after indicated treatments. Dispersion measures as in ( b ). d Representative cells expressing CENP-A-GFP and centrin1-GFP (cyan, centrioles circled) immunostained for pT232-Aurora B (red) and α-tubulin (gray) after continuous CENP-E inhibition and acute Aurora A inhibition by MLN8054 and <t>TCS7010,</t> with enlarged insets of polar (P) and aligned (A) kinetochores. e – g Quantification of pT232-Aurora B intensity ratio on polar vs. aligned kinetochores e , number of polar chromosomes f , and spindle length g after indicated treatments. Dispersion measures as in ( b) . h RPE-1 cells expressing CENP-A-GFP and centrin-GFP (red, centrioles circled), immunostained for α-tubulin (gray), and imaged by super-resolution Airyscan microscopy showing enlarged insets of congressing (C) and aligned (A) kinetochores. Images are deconvolved projections of 2–5 z-planes. Numbers: b 23, 18, 14, 27 cells averaged from 491 kinetochore pairs, c 83, 71, 61, 57, 47, 41, 52, 79 kinetochore pairs from 91 cells, e 22, 19, 17, 18 cells averaged from 436 kinetochore pairs, f , g 39, 38, 42, 38 cells, all pooled from ≥2 independent biological replicates. Statistics: two-tailed ANOVA with post-hoc Tukey’s HSD test. Symbols indicate: n.s., p > 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; ****, p ≤ 0.0001; inh., inhibited; chrom., chromosomes; MLN, MLN8237. Source data are provided as a Source Data file.
Aurora B Inhibitory Activity, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aurora b inhibitory activity/product/MedChemExpress
Average 94 stars, based on 1 article reviews
aurora b inhibitory activity - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
Selleck Chemicals tcs7010
a Representative RPE-1 cells expressing CENP-A-GFP and centrin1-GFP (gray, centrioles circled) after indicated treatments, showing enlarged insets of polar (P) and aligned (A) kinetochores immunostained for pT232-Aurora B (red). b Ratio of pT232-Aurora B intensity normalized to CENP-A on polar vs. aligned kinetochores per cell under indicated treatments. Colored points represent individual cells; black lines show the mean, with light and dark gray areas marking 95% confidence intervals for the mean and standard deviation, respectively. c Average pT232-Aurora B levels normalized to CENP-A on all kinetochore groups after indicated treatments. Dispersion measures as in ( b ). d Representative cells expressing CENP-A-GFP and centrin1-GFP (cyan, centrioles circled) immunostained for pT232-Aurora B (red) and α-tubulin (gray) after continuous CENP-E inhibition and acute Aurora A inhibition by MLN8054 and <t>TCS7010,</t> with enlarged insets of polar (P) and aligned (A) kinetochores. e – g Quantification of pT232-Aurora B intensity ratio on polar vs. aligned kinetochores e , number of polar chromosomes f , and spindle length g after indicated treatments. Dispersion measures as in ( b) . h RPE-1 cells expressing CENP-A-GFP and centrin-GFP (red, centrioles circled), immunostained for α-tubulin (gray), and imaged by super-resolution Airyscan microscopy showing enlarged insets of congressing (C) and aligned (A) kinetochores. Images are deconvolved projections of 2–5 z-planes. Numbers: b 23, 18, 14, 27 cells averaged from 491 kinetochore pairs, c 83, 71, 61, 57, 47, 41, 52, 79 kinetochore pairs from 91 cells, e 22, 19, 17, 18 cells averaged from 436 kinetochore pairs, f , g 39, 38, 42, 38 cells, all pooled from ≥2 independent biological replicates. Statistics: two-tailed ANOVA with post-hoc Tukey’s HSD test. Symbols indicate: n.s., p > 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; ****, p ≤ 0.0001; inh., inhibited; chrom., chromosomes; MLN, MLN8237. Source data are provided as a Source Data file.
Tcs7010, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tcs7010/product/Selleck Chemicals
Average 93 stars, based on 1 article reviews
tcs7010 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

94
MedChemExpress tc s7010
Aurora kinases regulate the expression of α-satellite RNA. ( A ) Representative western blotting demonstrates the inhibition of Aurora kinases in synchronized cells. AURKA inhibitor, <t>TC-S7010</t> (2.5 μM); AURKB inhibitor, AZD1152 (0.25 μM). H3S10P serves as positive control; ACTB, β-actin, serves as the internal loading control. ( B ) Quantification of H3S10P western blot in (A). ( C ) RT-qPCR analysis showing relative α-satellite RNA levels upon Aurora kinase inhibition. DMSO, no drug control. Results are normalized to Async no drug control. The error bars represent SD, n = 6. Statistical significance is calculated using unpaired t-tests and is reported as P < 0.05 *, P < 0.01 **, P < 0.001 ***, P < 0.0001 ****. ( D ) Representative images of α-satellite RNAs (αSAT) smFISH, CREST, and H3S10P IF in cells treated with Aurora kinase inhibitors. Scale bar, 10 μm.
Tc S7010, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tc s7010/product/MedChemExpress
Average 94 stars, based on 1 article reviews
tc s7010 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

Image Search Results


A HeLa cells were transfected with AURKA siRNA-1, AURKA siRNA-2, or control siRNA. These cells were treated with BMH-21 or DMSO, and were synchronized at M phase by nocodazole and harvested by shaking off. Immunoprecipitation was performed with anti-pan-phospho-serine/threonine antibody. The immunoprecipitates were immunoblotted with the indicated antibodies. B HeLa cells were transfected with the indicated doses of Flag-AURKA plasmid or Flag-vector. These cells were treated with BMH-21 or DMSO, and were synchronized at M phase and harvested as described in ( A ). Immunoprecipitation was performed with anti-pan-phospho-serine/threonine antibody. The immunoprecipitates were immunoblotted with the indicated antibodies. C HeLa cells were treated with 0 μM, 5 μM, 10 μM, and 15 μM TCS7010. These cells were treated with BMH-21 or DMSO, and were synchronized at M phase and harvested as described in ( A ). Immunoprecipitation was performed with anti-pan-phospho-serine/threonine antibody. The immunoprecipitates were immunoblotted with the indicated antibodies. D In vitro phosphorylation experiment was performed using purified His-AURKA and GST-SMC2. Proteins were resolved by SDS-PAGE and probed with anti-pan-phospho-lysine antibody. Coomassie blue staining showed the purified proteins. E Sequence alignment of the AURKA phosphorylation consensus within SMC2 and substrates of AURKA. Phosphorylated threonine residues are highlighted in red, arginine at the n − 3 position is highlighted in green, and hydrophobic residues at the n + 1 position are highlighted in blue. F In vitro phosphorylation experiment was performed using purified His-AURKA and GST-SMC2 T574A. Proteins were resolved by SDS-PAGE and probed with the indicated antibodies. Coomassie blue staining showed the purified proteins. G HeLa cells were transfected with the indicated siRNAs and the indicated plasmids (left). A quantitative comparison of multinucleated cells in HeLa cells in the indicated circumstances is shown ( n > 500) (right). ** p < 0.01. *** p < 0.001. **** p < 0.0001. n.s. denotes no significance.

Journal: Cell Death & Disease

Article Title: Pre-rRNAs control mitosis by maintaining chromosomal segregation through protecting SMC2 from AURKA-mediated phosphorylation

doi: 10.1038/s41419-025-08169-9

Figure Lengend Snippet: A HeLa cells were transfected with AURKA siRNA-1, AURKA siRNA-2, or control siRNA. These cells were treated with BMH-21 or DMSO, and were synchronized at M phase by nocodazole and harvested by shaking off. Immunoprecipitation was performed with anti-pan-phospho-serine/threonine antibody. The immunoprecipitates were immunoblotted with the indicated antibodies. B HeLa cells were transfected with the indicated doses of Flag-AURKA plasmid or Flag-vector. These cells were treated with BMH-21 or DMSO, and were synchronized at M phase and harvested as described in ( A ). Immunoprecipitation was performed with anti-pan-phospho-serine/threonine antibody. The immunoprecipitates were immunoblotted with the indicated antibodies. C HeLa cells were treated with 0 μM, 5 μM, 10 μM, and 15 μM TCS7010. These cells were treated with BMH-21 or DMSO, and were synchronized at M phase and harvested as described in ( A ). Immunoprecipitation was performed with anti-pan-phospho-serine/threonine antibody. The immunoprecipitates were immunoblotted with the indicated antibodies. D In vitro phosphorylation experiment was performed using purified His-AURKA and GST-SMC2. Proteins were resolved by SDS-PAGE and probed with anti-pan-phospho-lysine antibody. Coomassie blue staining showed the purified proteins. E Sequence alignment of the AURKA phosphorylation consensus within SMC2 and substrates of AURKA. Phosphorylated threonine residues are highlighted in red, arginine at the n − 3 position is highlighted in green, and hydrophobic residues at the n + 1 position are highlighted in blue. F In vitro phosphorylation experiment was performed using purified His-AURKA and GST-SMC2 T574A. Proteins were resolved by SDS-PAGE and probed with the indicated antibodies. Coomassie blue staining showed the purified proteins. G HeLa cells were transfected with the indicated siRNAs and the indicated plasmids (left). A quantitative comparison of multinucleated cells in HeLa cells in the indicated circumstances is shown ( n > 500) (right). ** p < 0.01. *** p < 0.001. **** p < 0.0001. n.s. denotes no significance.

Article Snippet: TCS7010 (S1451) was purchased from Selleck.

Techniques: Transfection, Control, Immunoprecipitation, Plasmid Preparation, In Vitro, Phospho-proteomics, Purification, SDS Page, Staining, Sequencing, Comparison

A Dot blotting was performed with non-T574 phospho-SMC2 peptide or T574 phospho-SMC2 peptide to detect the specificity of anti-SMC2 T574-P antibody. B HeLa cells were treated with the indicated reagents. These cells were synchronized at M phase by thymidine double blocking and harvested by shaking off. Proteins were resolved by SDS-PAGE and probed with the indicated antibodies. Alpha-tubulin was used as a loading control. C HeLa cells were transfected with the indicated plasmids and treated with BMH-21 or not. These cells were synchronized at M phase by nocodazole and harvested by shaking off. Co-immunoprecipitation was performed with anti-Flag antibody, and the phosphorylation levels of Flag-SMC2 were evaluated by western blot using anti-SMC2 T574-P antibody. Alpha-tubulin was used as a loading control. D HeLa cells were transfected with the indicated siRNAs and treated with BMH-21 or not. These cells were synchronized and harvested as described in ( C ). Proteins were resolved by SDS-PAGE and probed with the indicated antibodies. Alpha-tubulin was used as a loading control. E HeLa cells were transfected with the indicated doses of Flag-AURKA or Flag vector and treated with BMH-21 or not. These cells were synchronized and harvested as described in ( C ). Proteins were resolved by SDS-PAGE and probed with the indicated antibodies. Alpha-tubulin was used as a loading control. F HeLa cells were treated with the indicated doses of TCS7010 or MLN8237, and treated with BMH-21 or not. These cells were synchronized and harvested as described in ( C ). Proteins were resolved by SDS-PAGE and probed with the indicated antibodies. Alpha-tubulin was used as a loading control. G HeLa cells were treated with Act D, BMH-21, or DMSO. These cells were fixed, and indirect immunofluorescent staining was performed using anti-SMC2 T574-P antibody. Chromosomes were stained by DAPI. Scale bar, 8 μm.

Journal: Cell Death & Disease

Article Title: Pre-rRNAs control mitosis by maintaining chromosomal segregation through protecting SMC2 from AURKA-mediated phosphorylation

doi: 10.1038/s41419-025-08169-9

Figure Lengend Snippet: A Dot blotting was performed with non-T574 phospho-SMC2 peptide or T574 phospho-SMC2 peptide to detect the specificity of anti-SMC2 T574-P antibody. B HeLa cells were treated with the indicated reagents. These cells were synchronized at M phase by thymidine double blocking and harvested by shaking off. Proteins were resolved by SDS-PAGE and probed with the indicated antibodies. Alpha-tubulin was used as a loading control. C HeLa cells were transfected with the indicated plasmids and treated with BMH-21 or not. These cells were synchronized at M phase by nocodazole and harvested by shaking off. Co-immunoprecipitation was performed with anti-Flag antibody, and the phosphorylation levels of Flag-SMC2 were evaluated by western blot using anti-SMC2 T574-P antibody. Alpha-tubulin was used as a loading control. D HeLa cells were transfected with the indicated siRNAs and treated with BMH-21 or not. These cells were synchronized and harvested as described in ( C ). Proteins were resolved by SDS-PAGE and probed with the indicated antibodies. Alpha-tubulin was used as a loading control. E HeLa cells were transfected with the indicated doses of Flag-AURKA or Flag vector and treated with BMH-21 or not. These cells were synchronized and harvested as described in ( C ). Proteins were resolved by SDS-PAGE and probed with the indicated antibodies. Alpha-tubulin was used as a loading control. F HeLa cells were treated with the indicated doses of TCS7010 or MLN8237, and treated with BMH-21 or not. These cells were synchronized and harvested as described in ( C ). Proteins were resolved by SDS-PAGE and probed with the indicated antibodies. Alpha-tubulin was used as a loading control. G HeLa cells were treated with Act D, BMH-21, or DMSO. These cells were fixed, and indirect immunofluorescent staining was performed using anti-SMC2 T574-P antibody. Chromosomes were stained by DAPI. Scale bar, 8 μm.

Article Snippet: TCS7010 (S1451) was purchased from Selleck.

Techniques: Blocking Assay, SDS Page, Control, Transfection, Immunoprecipitation, Phospho-proteomics, Western Blot, Plasmid Preparation, Staining

a Representative RPE-1 cells expressing CENP-A-GFP and centrin1-GFP (gray, centrioles circled) after indicated treatments, showing enlarged insets of polar (P) and aligned (A) kinetochores immunostained for pT232-Aurora B (red). b Ratio of pT232-Aurora B intensity normalized to CENP-A on polar vs. aligned kinetochores per cell under indicated treatments. Colored points represent individual cells; black lines show the mean, with light and dark gray areas marking 95% confidence intervals for the mean and standard deviation, respectively. c Average pT232-Aurora B levels normalized to CENP-A on all kinetochore groups after indicated treatments. Dispersion measures as in ( b ). d Representative cells expressing CENP-A-GFP and centrin1-GFP (cyan, centrioles circled) immunostained for pT232-Aurora B (red) and α-tubulin (gray) after continuous CENP-E inhibition and acute Aurora A inhibition by MLN8054 and TCS7010, with enlarged insets of polar (P) and aligned (A) kinetochores. e – g Quantification of pT232-Aurora B intensity ratio on polar vs. aligned kinetochores e , number of polar chromosomes f , and spindle length g after indicated treatments. Dispersion measures as in ( b) . h RPE-1 cells expressing CENP-A-GFP and centrin-GFP (red, centrioles circled), immunostained for α-tubulin (gray), and imaged by super-resolution Airyscan microscopy showing enlarged insets of congressing (C) and aligned (A) kinetochores. Images are deconvolved projections of 2–5 z-planes. Numbers: b 23, 18, 14, 27 cells averaged from 491 kinetochore pairs, c 83, 71, 61, 57, 47, 41, 52, 79 kinetochore pairs from 91 cells, e 22, 19, 17, 18 cells averaged from 436 kinetochore pairs, f , g 39, 38, 42, 38 cells, all pooled from ≥2 independent biological replicates. Statistics: two-tailed ANOVA with post-hoc Tukey’s HSD test. Symbols indicate: n.s., p > 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; ****, p ≤ 0.0001; inh., inhibited; chrom., chromosomes; MLN, MLN8237. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Kinetochore-centrosome feedback linking CENP-E and Aurora kinases controls chromosome congression

doi: 10.1038/s41467-025-64804-1

Figure Lengend Snippet: a Representative RPE-1 cells expressing CENP-A-GFP and centrin1-GFP (gray, centrioles circled) after indicated treatments, showing enlarged insets of polar (P) and aligned (A) kinetochores immunostained for pT232-Aurora B (red). b Ratio of pT232-Aurora B intensity normalized to CENP-A on polar vs. aligned kinetochores per cell under indicated treatments. Colored points represent individual cells; black lines show the mean, with light and dark gray areas marking 95% confidence intervals for the mean and standard deviation, respectively. c Average pT232-Aurora B levels normalized to CENP-A on all kinetochore groups after indicated treatments. Dispersion measures as in ( b ). d Representative cells expressing CENP-A-GFP and centrin1-GFP (cyan, centrioles circled) immunostained for pT232-Aurora B (red) and α-tubulin (gray) after continuous CENP-E inhibition and acute Aurora A inhibition by MLN8054 and TCS7010, with enlarged insets of polar (P) and aligned (A) kinetochores. e – g Quantification of pT232-Aurora B intensity ratio on polar vs. aligned kinetochores e , number of polar chromosomes f , and spindle length g after indicated treatments. Dispersion measures as in ( b) . h RPE-1 cells expressing CENP-A-GFP and centrin-GFP (red, centrioles circled), immunostained for α-tubulin (gray), and imaged by super-resolution Airyscan microscopy showing enlarged insets of congressing (C) and aligned (A) kinetochores. Images are deconvolved projections of 2–5 z-planes. Numbers: b 23, 18, 14, 27 cells averaged from 491 kinetochore pairs, c 83, 71, 61, 57, 47, 41, 52, 79 kinetochore pairs from 91 cells, e 22, 19, 17, 18 cells averaged from 436 kinetochore pairs, f , g 39, 38, 42, 38 cells, all pooled from ≥2 independent biological replicates. Statistics: two-tailed ANOVA with post-hoc Tukey’s HSD test. Symbols indicate: n.s., p > 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; ****, p ≤ 0.0001; inh., inhibited; chrom., chromosomes; MLN, MLN8237. Source data are provided as a Source Data file.

Article Snippet: Aurora A inhibitor TCS7010 (MedChemExpress, IC 50 value 3.4 nM) at a final concentration of 100 nM, was added 30 minutes before fixation.

Techniques: Expressing, Standard Deviation, Dispersion, Inhibition, Microscopy, Two Tailed Test

Aurora kinases regulate the expression of α-satellite RNA. ( A ) Representative western blotting demonstrates the inhibition of Aurora kinases in synchronized cells. AURKA inhibitor, TC-S7010 (2.5 μM); AURKB inhibitor, AZD1152 (0.25 μM). H3S10P serves as positive control; ACTB, β-actin, serves as the internal loading control. ( B ) Quantification of H3S10P western blot in (A). ( C ) RT-qPCR analysis showing relative α-satellite RNA levels upon Aurora kinase inhibition. DMSO, no drug control. Results are normalized to Async no drug control. The error bars represent SD, n = 6. Statistical significance is calculated using unpaired t-tests and is reported as P < 0.05 *, P < 0.01 **, P < 0.001 ***, P < 0.0001 ****. ( D ) Representative images of α-satellite RNAs (αSAT) smFISH, CREST, and H3S10P IF in cells treated with Aurora kinase inhibitors. Scale bar, 10 μm.

Journal: Nucleic Acids Research

Article Title: Chromatin-associated α-satellite RNA maintains chromosome stability by reestablishing SAF-A in the mitotic cell cycle

doi: 10.1093/nar/gkaf294

Figure Lengend Snippet: Aurora kinases regulate the expression of α-satellite RNA. ( A ) Representative western blotting demonstrates the inhibition of Aurora kinases in synchronized cells. AURKA inhibitor, TC-S7010 (2.5 μM); AURKB inhibitor, AZD1152 (0.25 μM). H3S10P serves as positive control; ACTB, β-actin, serves as the internal loading control. ( B ) Quantification of H3S10P western blot in (A). ( C ) RT-qPCR analysis showing relative α-satellite RNA levels upon Aurora kinase inhibition. DMSO, no drug control. Results are normalized to Async no drug control. The error bars represent SD, n = 6. Statistical significance is calculated using unpaired t-tests and is reported as P < 0.05 *, P < 0.01 **, P < 0.001 ***, P < 0.0001 ****. ( D ) Representative images of α-satellite RNAs (αSAT) smFISH, CREST, and H3S10P IF in cells treated with Aurora kinase inhibitors. Scale bar, 10 μm.

Article Snippet: To inhibit Aurora kinases, 2.5 μM of TC-S7010 (MedChemExpress) and 0.25 μM of AZD1152 (MedChemExpress) were added to the culture medium 0.5 h before sample collection [ , ].

Techniques: Expressing, Western Blot, Inhibition, Positive Control, Control, Quantitative RT-PCR